1236 related articles for article (PubMed ID: 25860354)
41. Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis.
Håkansson I; Tisell A; Cassel P; Blennow K; Zetterberg H; Lundberg P; Dahle C; Vrethem M; Ernerudh J
J Neuroinflammation; 2018 Jul; 15(1):209. PubMed ID: 30021640
[TBL] [Abstract][Full Text] [Related]
42. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
43. Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis.
Hradilek P; Revendova KZ; Horakova J; Bunganic R; Pelisek O; Zeman D; Hanzlikova P; Kusnierova P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Mar; 167(1):30-35. PubMed ID: 36695545
[TBL] [Abstract][Full Text] [Related]
44. Soluble CD163 from activated macrophages predicts mortality in acute liver failure.
Møller HJ; Grønbaek H; Schiødt FV; Holland-Fischer P; Schilsky M; Munoz S; Hassanein T; Lee WM;
J Hepatol; 2007 Nov; 47(5):671-6. PubMed ID: 17629586
[TBL] [Abstract][Full Text] [Related]
45. CSF inflammatory biomarkers responsive to treatment in progressive multiple sclerosis capture residual inflammation associated with axonal damage.
Romme Christensen J; Komori M; von Essen MR; Ratzer R; Börnsen L; Bielekova B; Sellebjerg F
Mult Scler; 2019 Jun; 25(7):937-946. PubMed ID: 29775134
[TBL] [Abstract][Full Text] [Related]
46. Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
Lindén M; Khademi M; Lima Bomfim I; Piehl F; Jagodic M; Kockum I; Olsson T
Mult Scler; 2013 Jun; 19(7):863-70. PubMed ID: 23175382
[TBL] [Abstract][Full Text] [Related]
47. The Macrophage Activation Marker Soluble CD163 is Longitudinally Associated With Insulin Sensitivity and β-cell Function.
Semnani-Azad Z; Connelly PW; Johnston LW; Retnakaran R; Harris SB; Zinman B; Hanley AJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):e285-94. PubMed ID: 31677389
[TBL] [Abstract][Full Text] [Related]
48. Serum markers of macrophage activation in pre-eclampsia: no predictive value of soluble CD163 and neopterin.
Kronborg CS; Knudsen UB; Moestrup SK; Allen J; Vittinghus E; Møller HJ
Acta Obstet Gynecol Scand; 2007; 86(9):1041-6. PubMed ID: 17712642
[TBL] [Abstract][Full Text] [Related]
49. Association of cerebrospinal fluid levels of lateral olfactory tract usher substance (LOTUS) with disease activity in multiple sclerosis.
Takahashi K; Kurihara Y; Suzuki Y; Goshima Y; Tanaka F; Takei K
JAMA Neurol; 2015 Feb; 72(2):176-9. PubMed ID: 25437093
[TBL] [Abstract][Full Text] [Related]
50. Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C.
Kazankov K; Barrera F; Møller HJ; Bibby BM; Vilstrup H; George J; Grønbaek H
Hepatology; 2014 Aug; 60(2):521-30. PubMed ID: 24623375
[TBL] [Abstract][Full Text] [Related]
51. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
Matsushita T; Tateishi T; Isobe N; Yonekawa T; Yamasaki R; Matsuse D; Murai H; Kira J
PLoS One; 2013; 8(4):e61835. PubMed ID: 23637915
[TBL] [Abstract][Full Text] [Related]
52. Macrophage-derived soluble CD163 level in young patients with Gaucher disease: relation to phenotypes, disease severity and complications.
Adly AAM; Ismail EAR; Ibraheem TM
Int Immunopharmacol; 2015 Feb; 24(2):416-422. PubMed ID: 25587690
[TBL] [Abstract][Full Text] [Related]
53. Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.
Agah E; Zardoui A; Saghazadeh A; Ahmadi M; Tafakhori A; Rezaei N
PLoS One; 2018; 13(1):e0190252. PubMed ID: 29346446
[TBL] [Abstract][Full Text] [Related]
54. Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies.
Martin SJ; McGlasson S; Hunt D; Overell J
J Neurol Neurosurg Psychiatry; 2019 Sep; 90(9):1059-1067. PubMed ID: 31123141
[TBL] [Abstract][Full Text] [Related]
55. Serum levels of soluble CD163 as a specific marker of macrophage/monocyte activity in sarcoidosis patients.
Tanimura H; Mizuno K; Okamoto H
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jul; 32(2):99-105. PubMed ID: 26278688
[TBL] [Abstract][Full Text] [Related]
56. Increased serum levels of macrophage activation marker sCD163 in Dengue patients.
S S SG; Pillai AB; Ramachandrappa VS; T K; Dhodapkar R; Kah J; Rajendiran S
J Clin Virol; 2017 Jan; 86():62-67. PubMed ID: 27960133
[TBL] [Abstract][Full Text] [Related]
57. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
[TBL] [Abstract][Full Text] [Related]
58. Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
Kušnierová P; Zeman D; Hradílek P; Zapletalová O; Stejskal D
PLoS One; 2020; 15(5):e0233519. PubMed ID: 32437412
[TBL] [Abstract][Full Text] [Related]
59. Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
Komori M; Matsuyama Y; Nirasawa T; Thiele H; Becker M; Alexandrov T; Saida T; Tanaka M; Matsuo H; Tomimoto H; Takahashi R; Tashiro K; Ikegawa M; Kondo T
Ann Neurol; 2012 May; 71(5):614-23. PubMed ID: 22522477
[TBL] [Abstract][Full Text] [Related]
60. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
Brettschneider J; Petzold A; Junker A; Tumani H
Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
